← All stocks

FEMASYS INC

FEMY Net buying
CIK 0001339005 #5009 in the set updated 18 Sep 2026
Bought (12 mo)
$134.00K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$134.00K
+$134.00K against sales at will

By person

7 insiders · 5 transactions
0.0×

Kathy Lee-Sepsick holds only 0.0 times base salary in stock. $50.00K of shares against $542.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Kathy Lee-Sepsick last reported holding, valued at $3.20, the price Common Stock was last bought or sold at on the open market here, on 7 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Elefant Dov
Chief Financial Officer
$50.00K (1)
+$50.00K
15,625
$50.00K
Lee-Sepsick Kathy
Chief Executive Officer
$50.00K (1)
+$50.00K
15,625
$50.00K
Canning John Charles
Chief Operating Officer
$14.00K (1)
+$14.00K
4,375
$14.00K
Mifek Jeffrey Gerald
Chief Clinical-Medical Affairs
$10.00K (1)
+$10.00K
3,125
$10.00K
Sipos Jeremy Alexander
Chief Technology Officer
$10.00K (1)
+$10.00K
3,125
$10.00K
Currie Daniel Scott
Chief Operating Officer
86,275
$276.08K
+29.4%
Larsen Charles
Director
56
$179.16

No percentages here. This company's share count has moved by a factor of 7.2 over the window, from 8,375,027 to 60,390,686 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 24 Jun 2021